NCT02227797View on ClinicalTrials.gov

MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

January 19, 2015

Primary Completion Date

September 8, 2017

Study Completion Date

March 1, 2019

Conditions
Fungal Infection
Interventions
DRUG

Voriconazole

6 mg/kg to 12 mg/kg IV/PO every 12 hours depending on patient age and dose toleration of prior patients

Trial Locations (1)

55455

University of Minnesota Medical Center, Fairview, Minneapolis

All Listed Sponsors
lead

Masonic Cancer Center, University of Minnesota

OTHER

NCT02227797 - MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients | Biotech Hunter | Biotech Hunter